We found that REH cells harbouring the ETV6::RUNX fusion but no del(6q) were also vulnerable to over-expression of FOXO3, PRDM1 and FOXO1 suggesting therapeutic relevance of pathways dysregulated by these genes for a range of ALL patients. Here, FOXO3 is linked to acute lymphoblastic leukemia.